How menstrual cycle phases affect blood sugar during aerobic and HIIT exercise in women with Type 1 diabetes.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses continuous glucose monitors to record blood glucose responses in adult women with Type 1 diabetes during standardized aerobic and high-intensity interval training sessions. Sessions will be scheduled in different menstrual cycle phases to compare glucose behavior for each exercise type and phase. Researchers will model glucose trajectories and insulin adjustments to identify patterns linked to cycle phases. Results will be used to create exercise programming guidelines and to inform artificial pancreas algorithms that account for menstrual-cycle effects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Age between 18-45 years T1D with a diabetes duration for more than 2 years Glycated hemoglobin (HbA1c) \< 8.5% (\<69 mmol mol-1) Stable insulin regimen in the past 6 months with less than 20% change in total insulin daily dose Multiple daily injections or insulin pump Weekly physical activity of 90 min or more, but no practicing any sport as amateur or professional.

Exclusion Criteria:

Clinical conditions or use of medications (other than insulin) known to affect glycemic control (e.g., oral/parenteral steroids or metformin, among others).

Where it's running

• University of Valencia
  Valencia, Select One, Spain Recruiting

Study contacts

• Study coordinator: Rodrigo Martín-San Agustín, Dr.
• Email: rodrigo.martin@uv.es
• Phone: 0034963983855

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Hydration in women across life stages

  This study tests how well water and electrolyte drinks rehydrate women at different life stages after overnight fasting and fluid restriction.

  Recruiting at 2 sites PepsiCo Global R&D · Bradenton, Florida and 1 other locations · NCT07653620

• iLet Bionic Pancreas started through primary care for adults on insulin

  This project will test whether starting the iLet Bionic Pancreas through primary care helps adults with insulin-treated type 1 or type 2 diabetes lower their A1c more than routine care over 13 weeks.

  Recruiting University of Colorado, Denver · Aurora, Colorado and 1 other locations · NCT07011147

• How the menstrual cycle affects immune responses and recovery after exercise in women

  This study is testing how different phases of the menstrual cycle affect immune responses and recovery after exercise in healthy women aged 18-40.

  Recruiting University of Central Florida · Orlando, Florida · NCT06985420

• Evaluating a new insulin delivery system for children with newly diagnosed type 1 diabetes

  This study is testing a new insulin delivery system to see if it helps children and teens with newly diagnosed type 1 diabetes manage their blood sugar better than traditional methods.

  Recruiting National and Kapodistrian University of Athens · Athens · NCT06919029

• HLA-DRB1*04:01 genetics in adults with type 1 diabetes

  This test will look for the HLA-DRB1*04:01 gene in adults diagnosed with type 1 diabetes within the past six months.

  Recruiting at 5 sites GentiBio, Inc · San Francisco, California and 4 other locations · NCT06860516

• Testing blood samples for early diagnosis of type 1 diabetes and celiac disease

  This study is testing if a new way of checking blood samples can help find type 1 diabetes and celiac disease earlier in children.

  Recruiting Meyer Children's Hospital IRCCS · Florence, Italy · NCT06849622

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.